Jasbir Seehra
Director, CHIEF EXECUTIVE OFFICER · 1 filing · Latest: Apr 2, 2026
Keros Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
KROS | Jasbir Seehra | Director, CHIEF EXECUTIVE OFFICER | Apr 2, 2026 | Option Exercise | $0.30 | 55,000 | $16.5K | 440,708 |